Year: 2025
Type: article
Abstract: The COVID pandemic highlighted the importance of vaccine development and availability worldwide. Operation Warp-Speed in the United States accelerated vaccine production by several major pharmaceutical manufacturers, averting some of the normal administrative processes. The result has been a financial windfall for those companies. Some recent data has shown that the COVID vaccine can cause negative side effects in some patients. There are provisions in U.S. law that allow victims of vaccine injuries to recover compensation through the court system. However, even then tort remedies are limited by federal law. Since the review process was rushed during the pandemic, should tort immunity still be available to those pharmaceutical companies? This paper will discuss the legal and ethical issues involved in vaccine tort immunity.
Source: Laws
DOI: 10.3390/laws14060080
Authors: Tammy Cowart, Gregory L. Bock
Institution: The University of Texas at Tyler
Language: English
Subfield: Pharmacy
Field: Health Professions
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,689
Funder: University of Texas at Tyler
OpenAlex ID: W4415683657